Malignant gliomas are heterogeneous, diffuse and highly infiltrating by nature. Despite wide surgical resection and improvements in radio- and chemotherapies, the prognosis of patients with glioblastoma multiforme remains extremely poor, with a median survival time of only 14.5 months from diagnosis to death. Particular challenges for glioblastoma multiforme therapy are posed by limitations in ...

A physiotherapist treats patients with Glioblastoma multiforme. multiforme treatment includes chemotherapy, radiotherapy, and surgery, which are being continuously developed thus increase the survival of a cancer diagnosis. More specifically, 5-year rates Patients have many problems including muscle weakness, pulmonary dysfunction, fatigue, pain. In end, tend to decline in activities daily livi...

rare case of cerebellar glioblastoma multiforme and supratentorial oligodendroglioma presenting as synchronous primary brain tumors.

since 1951, it is now a weekly with 48 issues per year.

INTRODUCTION Glioblastoma multiforme is the most aggressive type of primary brain tumors, but there is a small percentage of patients who have a long-term survival and some exceptional cases who survive decades after surgical removal of tumor. PRESENTATION OF CASE In 1994, a 44 year-old man, suffering from intense headache and loss of strength of the left arm, was operated for a glioblastoma ...